Recce Pharmaceuticals
Trending Articles
Related Content
Regulatory
Recce granted Qualified Infectious Disease Product Designation
Recce, an early stage pharmaceutical company developing a new class of synthetic antibiotics, announced the US Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation for its lead compound RECCE 327
Design & Build
Recce constructs automated manufacturing facility to support clinical trials
Recce Limited , a preclinical stage pharmaceutical company engaged in the development of a new class of synthetic antibiotics, has completed construction of a wholly owned production facility in Macquarie Park, Sydney, with expected outputs capable of supporting RECCE 327 through both Phase I and Phase II human trials